Terms: = Sarcomas AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638
345 results:
1. HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?
Becker AK; Puladi B; Xie K; Cassataro A; Götzl R; Hölzle F; Beier JP; Knüchel-Clarke R; Braunschweig T
World J Surg Oncol; 2024 May; 22(1):131. PubMed ID: 38760830
[TBL] [Abstract] [Full Text] [Related]
2. Deciphering the role of FUS::ddit3 expression and tumor microenvironment in myxoid liposarcoma development.
Ranji P; Jonasson E; Andersson L; Filges S; Luna Santamaría M; Vannas C; Dolatabadi S; Gustafsson A; Myklebost O; Håkansson J; Fagman H; Landberg G; Åman P; Ståhlberg A
J Transl Med; 2024 Apr; 22(1):389. PubMed ID: 38671504
[TBL] [Abstract] [Full Text] [Related]
3. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
Lin Y; Cao Q; Hong A; Liang X
Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
[TBL] [Abstract] [Full Text] [Related]
4. ddit3-amplified or low-polysomic pleomorphic sarcomas without MDM2 amplification: Clinicopathological review and immunohistochemical profile of nine cases.
Mori T; Iwasaki T; Sonoda H; Kawaguchi K; Tomonaga T; Furukawa H; Sato C; Shiraishi S; Taguchi K; Tamiya S; Yoneda R; Oshiro Y; Matsunobu T; Abe C; Kuboyama Y; Ueki N; Kohashi K; Yamamoto H; Nakashima Y; Oda Y
Hum Pathol; 2024 Mar; 145():56-62. PubMed ID: 38401716
[TBL] [Abstract] [Full Text] [Related]
5. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
6. A single-cell atlas of conventional central chondrosarcoma reveals the role of endoplasmic reticulum stress in malignant transformation.
Su Z; Ho JWK; Yau RCH; Lam YL; Shek TWH; Yeung MCF; Chen H; Oreffo ROC; Cheah KSE; Cheung KSC
Commun Biol; 2024 Jan; 7(1):124. PubMed ID: 38267611
[TBL] [Abstract] [Full Text] [Related]
7. Rare myxoid pleomorphic liposarcoma: a case report and literature review.
Shen Y; Zhao L; Li A; Peng Q; Liu Q; Wang L; Liu Z
J Clin Pathol; 2024 Apr; 77(5):358-362. PubMed ID: 38123348
[TBL] [Abstract] [Full Text] [Related]
8. Gene of the month: ddit3.
Diaz-Perez JA; Kerr DA
J Clin Pathol; 2024 Mar; 77(4):211-216. PubMed ID: 38053287
[TBL] [Abstract] [Full Text] [Related]
9. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study.
Kojima N; Kubo T; Mori T; Satomi K; Matsushita Y; Iwata S; Yatabe Y; Ichimura K; Kawai A; Ichikawa H; Yoshida A
Virchows Arch; 2024 Jan; 484(1):71-81. PubMed ID: 37704823
[TBL] [Abstract] [Full Text] [Related]
10. Pancreatic follicular dendritic cell sarcoma: a rare case report and systematic literature review of 7 cases.
Li X; Gu J; He Q; Han S; Wu H
World J Surg Oncol; 2023 Jul; 21(1):212. PubMed ID: 37480085
[TBL] [Abstract] [Full Text] [Related]
11. Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/chop Stress Response Pathway.
Ludwig MP; Galbraith MD; Eduthan NP; Hill AA; Clay MR; Tellez CM; Wilky BA; Elias A; Espinosa JM; Sullivan KD
Cancer Res; 2023 Aug; 83(15):2543-2556. PubMed ID: 37205634
[TBL] [Abstract] [Full Text] [Related]
12. 18 F-FDG PET/CT in Extensive Follicular Dendritic Cell Sarcoma With Response Assessment to Chemotherapy.
Prakash KDJ; Sharma S; Nazar AH; Ora M; Gambhir S
Clin Nucl Med; 2023 Jul; 48(7):e347-e349. PubMed ID: 37167157
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract] [Full Text] [Related]
14. Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin.
Wei H; Du X; Zhao H; Sun P; Yang J
Int J Clin Pract; 2023; 2023():3093945. PubMed ID: 36756222
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report.
Watanabe H; Fujishima F; Motoi T; Aoyama Y; Niihori T; Takahashi M; Umegaki S; Oishi H; Tada H; Ichinohasama R; Sasano H
Diagn Pathol; 2022 Dec; 17(1):93. PubMed ID: 36514176
[TBL] [Abstract] [Full Text] [Related]
16. A cryptic EWSR1::ddit3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics.
Ibstedt S; de Mattos CBR; Köster J; Mertens F
Genes Chromosomes Cancer; 2023 Mar; 62(3):167-170. PubMed ID: 36379683
[TBL] [Abstract] [Full Text] [Related]
17. PRP-1, a toll-like receptor ligand, upregulates the unfolded protein response in human chondrosarcoma cells.
Galoian K; Dahl V; Perez A; Denny C; Becker B; Sedani A; Moran A; Martinez D; Hoyt A; Brown J
Cancer Treat Res Commun; 2022; 33():100644. PubMed ID: 36368296
[TBL] [Abstract] [Full Text] [Related]
18. Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis.
Varey AHR; Williams GJ; Lo SN; Taing CY; Maurichi A; Santinami M; Scolyer RA; Thompson JF
J Eur Acad Dermatol Venereol; 2023 May; 37(5):859-870. PubMed ID: 36251355
[TBL] [Abstract] [Full Text] [Related]
19. [Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases].
Zheng XC; Huang HJ; You J; Lin XY; Chen DR; Zhong D
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):738-742. PubMed ID: 35922164
[No Abstract] [Full Text] [Related]
20. 4D-CT as a second line preoperative localization test for the evaluation of primary hyperparathyroidism.
Barranquero AG; Pastor P; Ortega A; Corral S; Gómez Ramírez J; Luengo P; Porrero B; Cabañas LJ
Cir Esp (Engl Ed); 2023 Aug; 101(8):530-537. PubMed ID: 35905870
[TBL] [Abstract] [Full Text] [Related]
[Next]
